Autoantibodies to high mobility group box 1 in patients with Incomplete and Systemic Lupus ErythematosusSchaper, F., De Leeuw, K., Horst, G., Maas, F., Beijeren, D. V., Bijzet, J., Heeringa, P., Limburg, P. C. & Westra, J., 1-Jan-2015, p. 15. 1 p.
Research output: Contribution to conference › Abstract › Academic
Introduction. High Mobility Group Box-1 (HMGB1) is involved in the pathogenesis of Systemic Lupus Erythematosus (SLE). However, the role of autoantibodies to HMGB1 is unclear. Therefore levels of anti-HMGB1 and their reactivity to HMGB1 BoxA and BoxB were examined in association with disease activity and clinical parameters. Methods. Eighty-six SLE patients, 34 patients with incomplete lupus (ILE) and 44 age- and sex-matched healthy controls (HC) were included. Anti-HMGB1 levels were measured during quiescent disease (SLEDAI ≤4, n=47), and active disease (SLEDAI ≥5 n=39). Serum IgG, IgM anti-HMGB1 levels and reactivity against Box A and B were measured using ELISA. Results. Quiescent and active SLE patients had significantly increased anti- HMGB1 IgG levels compared to HC. There was no difference in anti-HMGB1 levels between active and quiescent patients. ILE patients did not have increased anti-HMGB1 levels. Anti-HMGB1 IgM in HC, ILE, quiescent and active SLE patients were comparable. There were no associations between anti-HMGB1 and disease activity, anti-ds DNA. However, patients with arthritis had higher anti- HMGB1 levels, while patients with neurological involvement had lower levels. Anti-HMGB1 levels were similar in active disease and subsequent remission. Patients with antibodies directed against both Box A and B had higher SLEDAI, increased anti-ds DNA, lower complement C3 levels, and higher total anti-HMGB1. Conclusion. Although anti-HMGB1 IgG levels are increased in SLE patients, no clear relation with disease activity or specific clinical symptoms was found. Therefore, anti-HMGB1 levels do not seem to be a useful biomarker of active disease or organ involvement.
|Number of pages||1|
|Publication status||Published - 1-Jan-2015|
|Event||11th International Congress on Systemic Lupus Erythematosus - |
Duration: 2-Sep-2015 → 6-Sep-2015
|Conference||11th International Congress on Systemic Lupus Erythematosus|
|Period||02/09/2015 → 06/09/2015|
11th International Congress on Systemic Lupus Erythematosus
02/09/2015 → 06/09/2015
- autoantibody, immunoglobulin G, double stranded DNA, immunoglobulin M, antibody, biological marker, DNA, systemic lupus erythematosus, patient, human, disease activity, serum, parameters, remission, arthritis, pathogenesis, SLEDAI, enzyme linked immunosorbent assay